Onconetix, Inc. Files 8-K Report
Ticker: ONCO · Form: 8-K · Filed: Apr 8, 2025 · CIK: 1782107
Sentiment: neutral
Topics: sec-filing, 8-k, corporate-disclosure
TL;DR
Onconetix (ONCO) filed a routine 8-K, nothing major to see here.
AI Summary
Onconetix, Inc. filed an 8-K on April 8, 2025, reporting other events and financial statements. The company, formerly known as Blue Water Biotech, Inc. and Blue Water Vaccines Inc., is incorporated in Delaware and headquartered in Cincinnati, Ohio. The filing does not disclose specific financial transactions or material events beyond the standard reporting requirements.
Why It Matters
This 8-K filing serves as a standard corporate disclosure, indicating Onconetix, Inc. is meeting its reporting obligations with the SEC.
Risk Assessment
Risk Level: low — The filing is a standard 8-K report and does not contain information indicating significant new risks or material adverse events.
Key Players & Entities
- Onconetix, Inc. (company) — Registrant
- Blue Water Biotech, Inc. (company) — Former Company Name
- Blue Water Vaccines Inc. (company) — Former Company Name
- April 8, 2025 (date) — Date of Report
- Delaware (jurisdiction) — State of Incorporation
- Cincinnati, Ohio (location) — Principal Executive Offices
FAQ
What is the primary purpose of this 8-K filing for Onconetix, Inc.?
The primary purpose of this 8-K filing is to report 'Other Events' and 'Financial Statements and Exhibits' as of April 8, 2025.
What were the previous names of Onconetix, Inc.?
Onconetix, Inc. was formerly known as Blue Water Biotech, Inc. (name change effective April 24, 2023) and Blue Water Vaccines Inc. (name change effective July 10, 2019).
Where are Onconetix, Inc.'s principal executive offices located?
Onconetix, Inc.'s principal executive offices are located at 201 E. Fifth Street, Suite 1900, Cincinnati, Ohio 45202.
In which state is Onconetix, Inc. incorporated?
Onconetix, Inc. is incorporated in Delaware.
What is the SIC code for Onconetix, Inc.?
The Standard Industrial Classification (SIC) code for Onconetix, Inc. is 2834, which corresponds to Pharmaceutical Preparations.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on April 8, 2025 regarding Onconetix, Inc. (ONCO).